Login / Signup

Long-Term Outcomes of Anti-Thyroid Drug Treatment in Childhood-Onset Graves' Disease.

Dolrutai PuttawongPat MahachoklertwattanaPawin NumthavajPatarawan WoratanaratB N S Sarunyu PongratanakulPeeravit KoadPreamrudee Poomthavorn
Published in: Clinical endocrinology (2022)
Remission rate of childhood-onset GD was relatively low following ATD treatment. Longer-term ATD therapy was associated with increased remission rate. Approximately 50% of patients with relapse had disease relapse within one year following ATD discontinuation. This article is protected by copyright. All rights reserved.
Keyphrases
  • preterm infants
  • mesenchymal stem cells
  • systemic lupus erythematosus
  • cell therapy